PTC Therapeutics Inc. sell Morgan Stanley
Start price
19.12.23
/
50%
€24.80
Target price
19.12.24
€25.54
Performance (%)
-4.84%
Price
25.04.24
€23.00
Summary
This prediction is currently active. With a performance of -4.84%, the SELL prediction by Morgan_Stanley is trending in the right direction. This prediction currently runs until 19.12.24. The prediction end date can be changed by Morgan_Stanley at any time. Morgan_Stanley has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| PTC Therapeutics Inc. | -0.862% | -0.862% |
| iShares Core DAX® | 2.594% | -1.158% |
| iShares Nasdaq 100 | 3.553% | -1.727% |
| iShares Nikkei 225® | 0.687% | -8.354% |
| iShares S&P 500 | 2.209% | -0.942% |
Comments by Morgan_Stanley for this prediction
In the thread PTC Therapeutics Inc. diskutieren
PTC Therapeutics, Inc. (NASDAQ: PTCT) was downgraded by analysts at Morgan Stanley from an "equal weight" rating to an "underweight" rating. They now have a $28.00 price target on the stock.
Ratings data for PTCT provided by MarketBeat